Xin Lang Cai Jing·2025-09-15 02:21Company Overview - Kanglong Chemical (Beijing) New Drug Technology Co., Ltd. was established on July 1, 2004, and went public on January 28, 2019. The company is located in Beijing Economic and Technological Development Zone [1] - The main business areas include drug research, development, and production services, with revenue composition as follows: laboratory services 60.43%, CMC (small molecule CDMO) services 21.58%, clinical research services 14.58%, macromolecule and cell & gene therapy services 3.28%, and others 0.12% [1] Stock Performance - On September 15, Kanglong Chemical's stock rose by 5.07%, reaching a price of 35.46 CNY per share, with a trading volume of 1.122 billion CNY and a turnover rate of 2.27%. The total market capitalization is 63.055 billion CNY [1] Fund Holdings - Southern Fund has a significant holding in Kanglong Chemical, with the Southern Growth Enterprise Board 2-Year Open Mixed Fund (160143) increasing its position by 85,200 shares in the second quarter, bringing the total to 318,000 shares, which accounts for 3.15% of the fund's net value, making it the fourth-largest holding [2] - The fund has a current size of 248 million CNY and has achieved a year-to-date return of 40.91%, ranking 1426 out of 8246 in its category. Over the past year, the return is 73.43%, ranking 1375 out of 8054 [2]